Bloomberg Law
Free Newsletter Sign Up
Bloomberg Law
Free Newsletter Sign Up

Pfizer Recalls 6 Lots of Accuretic Tablets, 1 Lot of Quinapril

March 21, 2022, 8:40 PM

Pfizer is voluntarily recalling Accuretic tablets distributed by the company as well as two generics by Greenstone due to the presence of a nitrosamine, N-nitroso-quinapril, above the acceptable level.

  • Pfizer will recall six lots of Accuretic tablets, one lot of quinapril and hydrochlorothiazide tablets and four lots of quinapril HCl/ hydrochlorothiazide tablets


  • Pfizer Inc. rose 0.1% in postmarket trading to $54.25 as of 4:39 p.m. New York time
    • The average 12-month price target of $59.36 is 9.4% above the current price
    • 14 buys, 13 holds, 1 sells

To view the source of this information, click here

To contact the ...